Enteric disease etsting market expected to Grow at 2.8% by 2031, Enteric diseases are caused by microscopic pathogens that enter the body through the mouth or intestinal route, fundamentally because of eating or drinking any contaminated foods or fluids. The immune system of the body and the strength of the pathogen cumulatively decide the fate of the infection whether it will be acute or chronic. The enteric pathogen can cause further complexities such as malabsorption of medications and immunological disorders. Abdominal cramps, loss of appetite, vomiting, diarrhea, blood in stools, fever and dehydration are few of the key symptoms of any enteric disease. Enteric infection has intense effect on childhood development and global mortality as well. According to the Centers for Disease Control and Prevention the enteric disease is a serious public health issue which causes around 48 million cases of illness and the treatment costs US$125 billion each year only in United States. The global enteric disease testing market can be segmented on the basis of type of pathogens such as viral pathogens, bacterial pathogens and parasitic pathogens. While on the basis of test type the global enteric disease testing market can be segmented into immunological test, molecular diagnostic test, rapid test, culture test and other test.
Financial and ecological factors, for example, poor sanitation and rising population living underneath the destitution line with unhygienic lifestyle, contaminated foods and water supply attribute to the rising incidences of enteric diseases which in turn impel the enteric disease testing market development. Technological advancement for enteric disease testing with the huge adoption rate of rapid test along with immunological and molecular test platforms propel the growth of the enteric disease testing market. The organizations like UNICEF or WHO have taken few initiatives for the enteric disease management that contributes high growth to the enteric disease testing market as well. The lack of awareness in public, poor financial condition, improper laboratory set-up and untrained health personnel in developing countries restrain the growth of the enteric disease testing market.
The North America is expected to dominate the enteric disease testing market due to its well organized healthcare infrastructure and healthcare expenditure. Large population, rising prevalence of enteric diseases, unhealthy lifestyle, improper sanitation and poor economic condition positively influence the growth of the enteric disease testing market in Asia-Pacific region.
Key Players Identified for Enteric Disease Testing Market include:
Abbott Laboratories, Becton Dickinson & Company, Biomerica, Inc., Bio-Rad Laboratories, Inc., Meridian Bioscience, Inc, Quest Diagnostics And Other Notable Players.
This report offers:
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Enteric Disease Testing market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2022-2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Year | 2022 |
Unit | USD Million |
Segmentation | |
Product
| |
Technique
| |
Disease
| |
End User
| |
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report